Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both

Department of Psychiatry and Behavioral Sciences, University of Washington Seattle, Seattle, Washington, United States
Neurology (Impact Factor: 8.3). 06/2005; 64(12):2069-73. DOI: 10.1212/01.WNL.0000165987.89198.65
Source: PubMed

ABSTRACT To examine the neuropsychological profile of dementia patients from a community-based autopsy sample of dementia, comparing Alzheimer disease (AD), Lewy body pathology (LBP) alone, and LBP with coexistent AD (AD/LBP).
The authors reviewed 135 subjects from a community-based study of dementia for whom autopsy and brain tissue was available. Diagnostic groups were determined according to standard neuropathologic methods and criteria, and the presence of LBs was determined using alpha-synuclein immunostaining. Neuropathologically defined diagnostic groups of AD, AD/LBP, and LBP were examined for differences on neuropsychological test performance at the time of initial study enrollment.
There were 48 patients with AD alone, 65 with LB and AD pathology (AD/LBP), and 22 with LBP alone (LBP alone). There were no significant differences between groups demographically or on performance of enrollment Mini-Mental State Examination (MMSE) or Dementia Rating Scale (DRS). AD patients performed worse than the LBP patients on memory measures (Fuld Object Memory Evaluation Delayed Recall, Wechsler Memory Scale Logical Memory Immediate and Delayed Recall; p < 0.05) and a naming task (Consortium to Establish a Registry for Alzheimer's Disease Naming; p < 0.05). LBP patients were more impaired than AD patients on executive function (Trail Making Test Part B; p < 0.05) and attention tasks (Wechsler Adult Intelligence Scale-Revised Digit Span; p < 0.05). Decline in MMSE and DRS scores over time were greatest in the patients with AD/LBP.
In a community-based sample of older, medically complicated patients with dementia, there are neuropsychological differences between dementia subtypes at the time of diagnosis. In particular, patients with Alzheimer disease (AD) alone and AD/Lewy body pathology (LBP) had more severe memory impairment than patients with LBP. LBP alone was associated with more severe executive dysfunction. Patients with AD/LBP had the most rapid rate of cognitive decline.

Download full-text


Available from: Walter A Kukull, Aug 05, 2015
  • Source
    • "In contrast, patients with AD pathology showed a decline between first and second recall, consistent with impaired learning or rapid forgetting as has been described previously in the literature [29] [30]. Our findings are consistent with neuropsychological studies showing that patients with AD perform more poorly on delayed recall than patients without AD diagnosed by neuropathologic finding [2] [4] [5] [7] [10]. They are also consistent with the power of delayed recall as well as cued recall tests to distinguish cerebrospinal fluid profiles consistent with AD [31]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We compared the sensitivity and specificity of two delayed recall scores from the Modified Mini-Mental State (3MS) test with consensus clinical diagnosis to differentiate cognitive impairment due to Alzheimer's disease (AD) versus non-AD pathologies. At a memory disorders clinic, 117 cognitively impaired patients were administered a baseline 3MS test and received a contemporaneous consensus clinical diagnosis. Their brains were examined after death about 5 years later. Using logistic regression with forward selection to predict pathologically defined AD versus non-AD, 10-min delayed recall entered first (p = 0.001), followed by clinical diagnosis (p = 0.02); 1-min delayed recall did not enter. 10-min delayed recall scores ≤4 (score range = 0-9) were 87% sensitive and 47% specific in predicting AD pathology; consensus clinical diagnosis was 82% sensitive and 45% specific. For the 57 patients whose initial Mini-Mental State Examination scores were ≥19 (the median), 3MS 10-min delayed recall scores ≤4 showed some loss of sensitivity (80%) but a substantial gain in specificity (77%). In conclusion, 10-min delayed recall score on the brief 3MS test distinguished between AD versus non-AD pathology about 5 years before death at least as well as consensus clinical diagnosis that requires much more comprehensive information and complex deliberation.
    Journal of Alzheimer's disease: JAD 11/2013; 39(3):575-582. DOI:10.3233/JAD-130524 · 4.15 Impact Factor
  • Source
    • "Les perspectives d'une telle e ´ chelle sont multiples. Dans la MA, les ré percussions de la pathologie de Lewy associé e sur le phé notype clinique (Johnson et al., 2005) et le pronostic (Kraybill et al., 2005 ; Olichney et al., 1998) restent mé connues. Le dé ficit cholinergique pré coce et sé vè re des maladies a ` corps de Lewy interroge e ´ galement sur l'influence de la pathologie de Lewy sur la ré ponse thé rapeutique aux inhibiteurs de l'acé tylcholinesté rase dans la MA (Samuel et al., 2000 ; Touchon et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Dementia with Lewy bodies (DLB) is the second cause of degenerative dementia in autopsy studies. In clinical pratice however, the prevalence of DLB is much lower with important intercenter variations. Among the reasons for this low sensitivity of DLB diagnosis are (1) the imprecision and subjectivity of the diagnostic criteria; (2) the underestimation of non-motor symptoms (REM-sleep behavior disorder, dysautonomia, anosmia); mostly (3) the nearly constant association of Lewy bodies with Alzheimer's disease pathology, which dominates the clinical phenotype. With the avenue of targeted therapies against the protein agregates, new clinical scales able to apprehend the coexistence of Lewy pathology in Alzheimer's disease are expected.
    Revue Neurologique 11/2013; 169(11):844–857. DOI:10.1016/j.neurol.2013.05.004 · 0.60 Impact Factor
  • Source
    • "In the cognitive sphere, DLB patients have more severe executive/attention impairments than AD patients do (Kraybill et al., 2005), even at the predementia stage (Jicha et al., 2010). However, the constructive apraxia and visual perception disturbances observed in DLB patients (but not in dementia-free PD patients) reflects the impairment of cortical structures (Aarsland et al., 2003; Calderon et al., 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of the present study was to establish whether performance in an action fluency task is of value in the differential diagnosis of Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). After collecting normative data on performance in an action fluency task and a conventional animal fluency task in a cohort of French-speaking healthy controls, we assessed AD and DLB patients. Only the action fluency score differed significantly between the two demented groups, with DLB patients performing worse than AD patients. However, a composite action and animal fluency score was found to be more effective for discriminating between these two groups.
    Journal of Clinical and Experimental Neuropsychology 02/2013; DOI:10.1080/13803395.2013.763907 · 2.16 Impact Factor
Show more